Treatment of acne in the aesthetic patient: A round table update.

Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2165 (Electronic) Linking ISSN: 14732130 NLM ISO Abbreviation: J Cosmet Dermatol Subsets: MEDLINE

Original Publication: Oxford, UK : Blackwell Science, c2002-

Acne Vulgaris*/therapy ; Acne Vulgaris*/complications ; Chemexfoliation*/methods; Adult ; Humans ; Female ; Dermabrasion ; Treatment Outcome ; Esthetics

Background: The popularity of social media appears to be increasing the acceptance of cosmetic treatments, prompting more consumers to seek cosmetic treatments. As the estimated prevalence of acne vulgaris among adult women may be as high as 54%, acne is commonly observed among patients presenting for cosmetic treatments. Concomitant treatment of acne in the aesthetic patient population will improve overall clinical outcomes.
Aims: The goal of this work was to deliver a high-quality ethical and evidence-based educational program to physicians and adjunctive health care providers to advance patient care.
Methods: This paper is based on a webcam presentation with roundtable discussion by several notable experts in their field.
Results: A range of topical medications, injectable products, chemical peels, and energy-based devices are available for treating acne vulgaris. In most instances, these are compatible with rejuvenation procedures in the aesthetic patient.
Conclusion: The growth of social media is raising awareness of aesthetic procedures and appears to be increasing the number of patients seeking aesthetic treatment. Educating patients about the importance of treating acne vulgaris can improve overall treatment outcomes. In most instances, the presence of acne is not a barrier to aesthetic care.
(© 2023 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)

Webster GF. The pathophysiology of acne. Cutis. 2005;76:4-7.
Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55:490-500.
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945-973.
Tan J, Thiboutot D, Gollnick H, et al. Development of an atrophic acne scar risk assessment tool. J Eur Acad Dermatol Venereol. 2017;31:1547-1554.
Tan J, Bourdès V, Bissonnette R, et al. Prospective study of pathogenesis of atrophic acne scars and role of macular erythema. J Drugs Dermatol. 2017;16:566-572.
Marron SE, Chernyshov PV, Tomas-Aragones L. Quality-of-life research in acne vulgaris: current status and future directions. Am J Clin Dermatol. 2019;20:527-538.
Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016;188:118-126.
Elbuluk N, Grimes P, Chien A, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22:829-836.
Tan J, Thiboutot D, Popp G, et al. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80:1691-1699.
Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the global Alliance to improve outcomes in acne. J Am Acad Dermatol. 2018;78:S1-S23.
Holzmann R, Shakery K. Postadolescent acne in females. Skin Pharmacol Physiol. 2014;27:3-8.
Tsankova E, Kappas A. Facial skin smoothness as an indicator of perceived trustworthiness and related traits. Perception. 2016;45:400-408.
Lai M, Oruç I, Barton JJ. The role of skin texture and facial shape in representations of age and identity. Cortex. 2013;49:252-265.
Jones AL, Kramer RS, Ward R. Signals of personality and health: the contributions of facial shape, skin texture, and viewing angle. J Exp Psychol Hum Percept Perform. 2012;38:1353-1361.
Ryan-Mosley T. Beauty filters are changing the way young girls see themselves. MIT Technology Review, April. 2021. https://www.technologyreview.com/2021/04/02/1021635/beauty-filters-young-girls-augmented-reality-social-media/;2: Accessed: February 22, 2023.
Chen J, Ishii M, Bater KL, et al. Association between the use of social media and photograph editing applications, self-esteem, and cosmetic surgery acceptance. JAMA Facial Plast Surg. 2019;21:361-367.
Rosen N, Muhn C. Zoom and social media drive the rise of cosmetic procedures. Health Insight https://www.healthinsight.ca/health-care-industry-news/zoom-and-social-media-driving-increased-demand-for-cosmetic-procedures/. Accessed February 18, 2023.
Zheng DX, Ning AY, Levoska MA, Xiang L, Wong C, Scott JF. Acne and social media: a cross-sectional study of content quality on TikTok. Pediatr Dermatol. 2021;38:336-338.
Dreno B, Amici JM, Demessant-Flavigny AL, et al. The impact of acne, atopic dermatitis, skin toxicities and scars on quality of life and the importance of a holistic treatment approach. Clin Cosmet Investig Dermatol. 2021;14:623-632.
Cetaphil® Deep Hydration. Galderma laboratories, LP; Fort Worth, TX.
Wang X, Zhang Z, Wu SC. Health benefits of Silybum marianum: phytochemistry, pharmacology, and applications. J Agric Food Chem. 2020;68:11644-11664.
Kim J, Lee YN, Lee J, et al. Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild-to-moderate acne vulgaris: a prospective, open-label pilot study. J Cosmet Dermatol. 2023;22:561-568.
Silymarin CF®. SkinCeuticals. https://www.skinceuticals.com/skincare/vitamin-c-serums/silymarin-cf/S77.html Accessed: February 22, 2023.
Fuller B, Smith D, Howerton A, Kern D. Anti-inflammatory effects of CoQ10 and colorless carotenoids. J Cosmet Dermatol. 2006;5:30-38.
Meixiong J, Ricco C, Vasavda C, Ho BK. Diet and acne: a systematic review. JAAD Int. 2022;7:95-112.
Kurokawa I, Layton AM, Ogawa R. Updated treatment for acne: targeted therapy based on pathogenesis. Dermatol Ther (Heidelb). 2021;11:1129-1139.
Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029.
Retin-A® (tretinoin) Cream/Gel/Liquid [Prescribing Information]. Valeant Pharmaceuticals North America LLC, Bridgewater, NJ.
Retacnyl® 0.025% Cream [Prescribing Information]. Galderma Laboratories, LP, Fort Worth, TX.
Differin® (adapalene) gel ftuPI, 2021, Galderma Laboratories LP, Fort Worth, TX.
Tazorac® (tazarotene) cream for topical use [Prescribing Information]. Allergan, Inc, Irvine, CA.
Arazlo® (tazarotene) Lotion [Prescribing Information]. Bausch Health US, LLC, Bridgewater, NJ.
Tanghetti EA, Stein Gold L, Del Rosso JQ, Lin T, Angel A, Pillai R. Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology. J Dermatolog Treat. 2021;32:391-398.
Aubert J, Piwnica D, Bertino B, et al. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene. Br J Dermatol. 2018;179:442-456.
Akleif® (trifarotene) cream for topical use Prescribing Information. Galderma Laboratories LP, Fort Worth, TX.
Blume-Peytavi U, Fowler J, Kemény L, et al. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2020;34:166-173.
Winlevi® (clascoterone) cream Prescribing Information. Sun Pharmaceutical Industries, Ltd., Cranbury, NJ.
Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156:621-630.
Aczone® (dapsone) gel for topical use [Prescribing Information]. Allergan, Inc., Irvine CA.
Draelos ZD, Carter E, Maloney JM, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56:439-439.e10.
Finacea® (azelaic acid) foam for topical use [Prescribing Information]. Leo Pharma Inc., Madison, NJ.
Epiduo® Forte (adapalene and benzoyl peroxide) gel Prescribing Information. Galderma Laboratories, LP., Fort Worth, TX.
Dréno B, Bissonnette R, Gagné-Henley A, et al. Prevention and reduction of atrophic acne scars with adapalene 0.3%/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison. Am J Clin Dermatol. 2018;19:275-286.
Twyneo® (tretinoin and benzoyl peroxide) Cream 0.1%/3% prescribing information. Galderma Laboratories; Fort Worth, TX.
Kontzias C, Zaino M, Feldman SR. Tretinoin 0.1% and benzoyl peroxide 3% cream for the treatment of facial acne vulgaris. Ann Pharmacother. 2023;10600280221147338.
Seysara® (sarecycline) Tablets for Oral Use [Prescribing Information 2019]. Almirall, LLC, Exton, PA.
Perche PO, Peck GM, Robinson L, Grada AFAJ, Feldman SR. Prescribing trends for acne vulgaris visits in the United States. Antibiotics (Basel). 2023;12:269.
Doryx® (doxycycline hyclate) Tablets [Prescribing Information]. Mayne Pharma, Raleigh, NC.
Baldwin H. Oral antibiotic treatment options for acne vulgaris. J Clin Aesthet Dermatol. 2020;13:26-32.
Pastori D, Cormaci VM, Marucci S, et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24:3169.
Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18:169-191.
Garg V, Choi JK, James WD, Barbieri JS. Long-term use of spironolactone for acne in women: a case series of 403 patients. J Am Acad Dermatol. 2021;84:1348-1355.
Absorica™ (isotretinoin) Capsules fouPI. Ranbaxy Laboratories Inc., Jacksonville, FL.
iPLEDGE® REMS. https://ipledgeprogram.com/#Main/AboutiPledge 2023.Accessed March 20,2023.
Lee G, Wolf JR, Somers KE. Administrative burden of iPLEDGE deters isotretinoin prescriptions: results from a survey of dermatologists. Cutis. 2022;110:44-47.
Jackson A. Chemical peels. Facial Plast Surg. 2014;30:26-34.
Kouris A, Platsidaki E, Christodoulou C, et al. Patients' self-esteem before and after chemical peeling procedure. J Cosmet Laser Ther. 2018;20:220-222.
Castillo DE, Keri JE. Chemical peels in the treatment of acne: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018;11:365-372.
Costa IMC, Damasceno PS, Costa MC, Gomes KGP. Review in peeling complications. J Cosmet Dermatol. 2017;16:319-326.
Karimipour DJ, Kang S, Johnson TM, et al. Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol. 2005;52:215-223.
Karimipour DJ, Karimipour G, Orringer JS. Microdermabrasion: an evidence-based review. Plast Reconstr Surg. 2010;125:372-377.
DiamondGlow®. Allergan, Inc., Irvine, CA.
Boen M, Brownell J, Patel P, Tsoukas MM. The role of photodynamic therapy in acne: an evidence-based review. Am J Clin Dermatol. 2017;18:311-321.
Oh SH, Ryu DJ, Han EC, Lee KH, Lee JH. A comparative study of topical 5-aminolevulinic acid incubation times in photodynamic therapy with intense pulsed light for the treatment of inflammatory acne. Dermatol Surg. 2009;35:1918-1926.
Ameluz® (aminolevulinic acid hydrochloride) topical gel 10% [Prescribing Information 2021]. Biofrontera Inc., Woburn, MA.
Reinhold U. A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis. Future Oncol. 2017;13:2413-2428.
Sakamoto FH, Lopes JD, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol. 2010;63:183-193.
Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616-622.
Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide. Dermatol Surg. 2016;42:804-827.
Gold MH, Sensing W, Biron JA. Clinical efficacy of home-use blue-light therapy for mild-to moderate acne. J Cosmet Laser Ther. 2011;13:308-314.
American Academy of Dermatology. Lasers and lights: How well do they treat acne? https://www.aad.org/public/diseases/acne/derm-treat/lasers-lights Accessed: March 27, 2023.
Scott AM, Stehlik P, Clark J, et al. Blue-light therapy for acne vulgaris: a systematic review and meta-analysis. Ann Fam Med. 2019;17:545-553.
Diogo MLG, Campos TM, Fonseca ESR, et al. Effect of blue light on acne vulgaris: a systematic review. Sensors (Basel). 2021;21:6943.
Babilas P, Schreml S, Szeimies RM, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42:93-104.
Domenico P, Dimitra K, Giuliana C, et al. Effective intense pulsed light protocol in the treatment of moderate to severe acne vulgaris. Front Med (Lausanne). 2022;9:946405.
Forever Clear® BBL. Sciton, Inc.; Palo Alto, CA.
TheraClear®X. STRATA Skin Sciences, Horsham, PA.
Cohen JL, Berlin A. Improving outcomes and compliance for acne patients. The Dermatologist. 2013. https://www.hmpgloballearningnetwork.com/site/thederm/site/cathlab/event/improving-outcomes-and-compliance-acne-patients; Accessed March 27, 2023.
Sakamoto FH, Doukas AG, Farinelli WA, et al. Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser. Lasers Surg Med. 2012;44:175-183.
AviClear™. Cutera; Brisbane, CA.
Goldberg D, Kothare A, Doucette M, et al. Selective photothermolysis with a novel 1726 nm laser beam: a safe and effective solution for acne vulgaris. J Cosmet Dermatol. 2023;22:486-496.
Accure Laser™ System. Accure Acne, Inc.; Boulder, CO.
Scopelliti MG, Kothare A, Karavitis M. A novel 1726-nm laser system for safe and effective treatment of acne vulgaris. Lasers Med Sci. 2022;37:3639-3647.
Fife D, Zachary CB. Combining techniques for treating acne scars. Curr Derm Rep. 2012;1:82-88.
Dierickx C, Larsson MK, Blomster S. Effectiveness and safety of acne scar treatment with nonanimal stabilized hyaluronic acid gel. Dermatol Surg. 2018;44:S10-S18.
Sapra S, Stewart JA, Mraud K, Schupp R. A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. Dermatol Surg. 2015;41:587-594.
Beer K. A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg. 2007;33(Suppl 2):S159-S167.
Sadick NS, Palmisano L. Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. J Dermatolog Treat. 2009;20:302-307.
Sadove R. Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. Aesthetic Plast Surg. 2009;33:113-116.
Lowe NJ. Dispelling the myth: appropriate use of poly-L-lactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006;20:2-6.
O'Daniel TG. Multimodal management of atrophic acne scarring in the aging face. Aesthetic Plast Surg. 2011;35:1143-1150.
Hession MT, Graber EM. Atrophic acne scarring: a review of treatment options. J Clin Aesthet Dermatol. 2015;8:50-58.
Azzalure® (Botulinum toxin Type A) [Summary of Product Characteristics]. Galderma Ltd., London, UK. https://www.medicines.org.uk/emc/product/6584/smpc Accessed March 16, 2023.
Rho NK, Gil YC. Botulinum neurotoxin type a in the treatment of facial seborrhea and acne: evidence and a proposed mechanism. Toxins (Basel). 2021;13:817.
Shah AR. Use of intradermal botulinum toxin to reduce sebum production and facial pore size. J Drugs Dermatol. 2008;7:847-850.
Birkett L, Dhar S, Singh P, Mosahebi A. Botulinum toxin a in the management of acne vulgaris: evidence and recommendations. Aesthet Surg J. 2022;42:NP507-NP509.
Restylane® Instructions for Use. Galderma Laboratories, LP, Fort Worth, TX.
Juvederm® Instructions for Use. Allergan Aesthetics, Irvine, CA.
Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29:34-48.
Kim EK, Hovsepian RV, Mathew P, Paul MD. Dermabrasion. Clin Plast Surg. 2011;38:391-395.
Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol. 1988;118:703-706.

Keywords: acne vulgaris; aesthetic patients; chemical peels; dermal fillers; topical medications

Date Created: 20230705 Date Completed: 20230814 Latest Revision: 20230814

20231215

10.1111/jocd.15913

37403516